Caplight Logo









NeoCura Bio-Medical Technology Co., Ltd.

NeoCura Bio-Medical Technology Co., Ltd.

Private
BeijingHealthcare & Life Scienceshttp://www.neocura.com.cn

Last Round

Series A

Extension

Dec 21, 2021

Total Funding Raised

$116.65M

Company Overview

NeoCura Bio-Medical Technology Co., Ltd. is a biotechnology company that develops an artificial intelligence (AI) medical platform intended to improve the precision diagnosis and treatment of tumors.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials, Medical AI

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Infrastructure

Keywords

neoantigen vaccinemRNA cancer vaccineAI drug discoveryRNA drug platformpersonalized cancer therapybioinformatics platformcancer immunotherapyAI biotechmRNA vaccinesneoantigen discoverymulti-omics analysisautomated drug designclinical stage biotechdrug co-development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeoCura Bio-Medical Technology Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

NeoCura Bio-Medical Technology Co., Ltd. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionDec 21, 2021
Series ADec 23, 2020

NeoCura Bio-Medical Technology Co., Ltd. Investors

Notable investors and investment history

InvestorRounds
Alwin CapitalSeries A
IDG CapitalSeries A
PICC Capital Insurance Asset ManagementSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 27, 2026

    Added Lastoria, a medical devices startup, as a customer.

NeoCura Bio-Medical Technology Co., Ltd. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NeoCura Bio-Medical Technology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NeoCura Bio-Medical Technology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Employee Range9
Year Founded2017
Last FundingDec 21, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.